Prognostic performance of a high-sensitivity cardiac troponin i assay in patients with Non-ST-Elevation acute coronary syndrome

Clinical Chemistry

Volumn 60, Issue 1, 2014, Pages 158-164

  May, Erin A Bohula ^a   Bonaca, Marc P ^a   Jarolim, Petr ^a   Antman, Elliott M ^a   Braunwald, Eugene ^a   Giugliano, Robert P ^a   Newby, L Kristin ^b   Sabatine, Marc S ^a   Morrow, David A ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b DUKE CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CARDIAC TROPONIN 1 CLIA KIT; CARDIOVASCULAR RISK; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; HEART DEATH; HEART INFARCTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NON ST SEGMENT ELEVATION ACUTE CORONARY SYNDROME; SCORING SYSTEM; SEX;

EID: 84891794663     PISSN: 00099147     EISSN: 15308561     Source Type: Journal    
DOI: 10.1373/clinchem.2013.206441     Document Type: Article

References (21)

1. Thygesen K, Alpert JS, Jaffe AS, Simoons ML, Chaitman BR, White HD, et al. Third universal definition of myocardial infarction. J Am Coll Cardiol 2012;60: 1581-98.
2. Antman EM, Tanasijevic MJ, Thompson B, Schactman M, McCabe CH, Cannon CP, et al. Cardiacspecific troponin I levels to predict the risk of mortality in patients with acute coronary syndromes. N Engl J Med 1996;335: 1342-9. (Pubitemid 26360452)
3. Heidenreich PA, Alloggiamento T, Melsop K, Mc- Donald KM, Go AS, Hlatky MA. The prognostic value of troponin in patients with non-ST elevation acute coronary syndromes: a meta-analysis. J Am Coll Cardiol 2001;38: 478-85. (Pubitemid 32721777)
4. Ottani F, Galvani M, Nicolini FA, Ferrini D, Pozzati A, Di Pasquale G, Jaffe AS. Elevated cardiac troponin levels predict the risk of adverse outcome in patients with acute coronary syndromes. Am Heart J 2000;140: 917-27.
5. de Lemos JA, Drazner MH, Omland T, Ayers CR, Khera A, Rohatgi A, et al. Association of troponin T detected with a highly sensitive assay and cardiac structure and mortality risk in the general population. JAMA 2010;304: 2503-12.
6. Wallace TW, Abdullah SM, Drazner MH, Das SR, Khera A, McGuire DK, et al. Prevalence and determinants of troponin T elevation in the general population. Circulation 2006;113: 1958-65.
7. Zethelius B, Johnston N, Venge P. Troponin I as a predictor of coronary heart disease and mortality in 70-year-old men: a community-based cohort study. Circulation 2006;113: 1071-8.
8. Omland T, de Lemos JA, Sabatine MS, Christophi CA, Rice MM, Jablonski KA, et al. A sensitive cardiac troponin T assay in stable coronary artery disease. N Engl J Med 2009;361: 2538-47.
9. Apple FS. A new season for cardiac troponin assays: it's time to keep a scorecard. Clin Chem 2009;55: 1303-6.
10. Aldous SJ, Richards M, Cullen L, Troughton R, Than M. Diagnostic and prognostic utility of early measurement with high-sensitivity troponin T assay in patients presenting with chest pain. CMAJ 2012;184:E260-8.
11. Sanchis J, Bardaji A, Bosch X, Loma-Osorio P, Marin F, Sanchez PL, et al. Usefulness of highsensitivity troponin T for the evaluation of patients with acute chest pain and no or minimal myocardial damage. Am Heart J 2012;164:194- 200 e1.
12. Apple FS, Simpson PA, Murakami MM. Defining the serum 99th percentile in a normal reference population measured by a high-sensitivity cardiac troponin I assay. Clin Biochem 2010;43: 1034-6.
13. Giannitsis E, Kurz K, Hallermayer K, Jarausch J, Jaffe AS, Katus HA. Analytical validation of a high-sensitivity cardiac troponin T assay. Clin Chem 2010;56: 254-61.
14. Giugliano RP, White JA, Bode C, Armstrong PW, Montalescot G, Lewis BS, et al. Early versus delayed, provisional eptifibatide in acute coronary syndromes. N Engl J Med 2009;360: 2176-90.
15. Sabatine MS, Antman EM, Widimsky P, Ebrahim IO, Kiss RG, Saaiman A, et al. Otamixaban for the treatment of patients with non-ST-elevation acute coronary syndromes (SEPIA-ACS1 TIMI 42): a randomised, double-blind, active-controlled, phase 2 trial. Lancet 2009;374: 787-95.
16. Apple FS, Collinson PO. Analytical characteristics of high-sensitivity cardiac troponin assays. Clin Chem 2012;58: 54-61.
17. Lipowsky CA, Laird D, Workman R, Ramp J, Drengler S, Gardiner M, et al. Development of a highly sensitive immunoassay for cardiac troponin I for the ARCHITECT i2000SR and i1000SR analyzers [Abstract]. Clin Chem 2012;58(Suppl):A5.
18. Antman EM, Cohen M, Bernink PJ, McCabe CH, Horacek T, Papuchis G, et al. The TIMI risk score for unstable angina/non-ST elevation mi: a method for prognostication and therapeutic decision making. JAMA 2000;284: 835-42. (Pubitemid 30643610)
19. Eggers KM, Jaffe AS, Lind L, Venge P, Lindahl B. Value of cardiac troponin I cutoff concentrations below the 99th percentile for clinical decisionmaking. Clin Chem 2009;55: 85-92.
20. Schulz O, Kirpal K, Stein J, Bensch R, Berghofer G, Schimke I, Jaffe AS. Importance of low concentrations of cardiac troponins. Clin Chem 2006;52: 1614-5. (Pubitemid 44148334)
21. Bonaca M, Scirica B, Sabatine M, Dalby A, Spinar J, Murphy SA, et al. Prospective evaluation of the prognostic implications of improved assay performance with a sensitive assay for cardiac troponin I. J Am Coll Cardiol 2010;55: 2118-24.